Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu

BA825A0F79F9FF2587258B020074CFB7 Hearing Summary




PUBLIC
BILL SUMMARY For HB24-1010

SENATE COMMITTEE ON HEALTH & HUMAN SERVICES
Date Apr 17, 2024      
Location SCR 357



HB24-1010 - Lay Over


03:15:57 PM  
Senator Michaelson Jenet, primary bill sponsor, presented House Bill 24-1010 which, for persons requiring a provider-administered prescription drug that is covered by a health insurer, the bill prohibits the insurance carriers from:
· requiring that provider-administered prescription drugs be dispensed only by specific network pharmacies;
· limiting coverage for provider-administered prescription drugs due to an insured person’s preferred participating provider;
· imposing additional fees or copays on provider-administered prescription drugs due to an insured person’s preferred participating provider; or
· requiring that providers bill certain provider-administered prescription drugs under the pharmacy benefit rather than the medical benefit without consent.
The bill also requires that the reimbursement rate for covered provider-administered drugs be at the carrier’s in-network rate for participating providers.
03:22:10 PM  
Mr. Patrick Boyle, representing Pharmacy Care Management Association, testified in opposition to the bill.

Ms. Saskia Young, representing Colorado Association of Health Plans, testified to amend the bill.

Karlee Tebbutt, representing America's Health Insurance Plans (AHIP), testified to amend the bill.

Debra Judy, representing Division of Insurance, testified to amend the bill.

Committee members asked the panel questions.

03:38:32 PM  
Dr. Leslie Busby, representing Rocky Mountain Cancer Centers, testified in support of the bill.

Dr. Emily Zadvorny, representing Colorado Pharmacists Society, testified to amend the bill.

Mr. Evan Slater, representing Rocky Mountain Cancer Centers, testified in support of the bill.

Joshua Ewing, representing Colorado Hospital Association, testified to amend the bill.

Additional written testimony was submitted to the committee (Attachment D).

Committee members asked the panel questions.